Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ilant Health vs WePeptideRx

Ilant Health
Graded #408

Lower grade

vs+4.600000000000001
WePeptideRx
Graded #297

Higher grade

The verdict

WePeptideRx takes it — 61.4/100 to 56.8/100.

WePeptideRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. WePeptideRx is a provider-guided telehealth platform offering compounded semaglutide and tirzepatide alongside a deep menu of peptide, hormone, hair, and sexual-wellness programs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWePeptideRx +3
45
48
Dose & formulationWePeptideRx +24
40
64
Clinical oversightIlant Health +2
83
81
Labs & monitoringIlant Health +8
61
53
FulfillmentWePeptideRx +5
62
67
Contract termsEven
55
55
Ilant Health · left barWePeptideRx · right bar

The numbers

MetricIlant HealthWePeptideRx
WeighScore56.8/10061.4/100
GradeCC
Scorecard rank#408#297
SemaglutideNot disclosed$249/mo (compounded)
TirzepatideNot disclosed$249/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Ilant Health

Graded #408 · C

Strengths

  • Value-based, outcomes-driven obesity care model
  • Includes GLP-1 medications with transparent drug pricing for sponsors
  • Care team of board-certified obesity providers and behavioral specialists
  • Dietitians and peer navigators support adherence
  • Data-driven stratification targets the right interventions

Where it loses points

  • Distributed via employers and health plans, not direct cash-pay
  • Individuals generally cannot enroll without sponsor coverage
  • No public consumer pricing for GLP-1
  • Access gated behind organizational buyers
  • Not suited to consumers wanting direct-to-door GLP-1
WePeptideRx

Graded #297 · C

Strengths

  • Pre-mixed ready-to-inject delivery skips the vial reconstitution and sharps hassle of most compounded providers
  • Microdose protocols (0.05–0.25 mg sema, 0.5–2.5 mg tirz) suit ultra-low-dose maintenance patients — uncommon in DTC
  • 12+ programs under one platform — GLP-1 plus longevity, sexual wellness, and hair
  • Physical Boca Raton address, phone, and business hours listed
  • LegitScript Certified and publishes the FDA disclaimer

Where it loses points

  • Pharmacy partner not named
  • 48-state claim, but the specific state list isn't shown on the homepage
  • Medical director not named on the homepage
  • Telemedicine is outsourced to a third-party provider network rather than in-house staff
  • Corporate legal entity and arbitration venue not disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard